Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21523916rdf:typepubmed:Citationlld:pubmed
pubmed-article:21523916lifeskim:mentionsumls-concept:C0001072lld:lifeskim
pubmed-article:21523916lifeskim:mentionsumls-concept:C0392347lld:lifeskim
pubmed-article:21523916lifeskim:mentionsumls-concept:C1524119lld:lifeskim
pubmed-article:21523916lifeskim:mentionsumls-concept:C0007222lld:lifeskim
pubmed-article:21523916lifeskim:mentionsumls-concept:C0872252lld:lifeskim
pubmed-article:21523916lifeskim:mentionsumls-concept:C2349209lld:lifeskim
pubmed-article:21523916lifeskim:mentionsumls-concept:C1549649lld:lifeskim
pubmed-article:21523916pubmed:issue5-6lld:pubmed
pubmed-article:21523916pubmed:dateCreated2011-5-27lld:pubmed
pubmed-article:21523916pubmed:abstractTextCardiovascular disease (CVD) is the major cause of mortality and morbidity worldwide. Diagnosis of CVD and risk stratification of patients with CVD remains challenging despite the availability of a wealth of non-invasive and invasive tests. Clinical proteomics analyses a large number of peptides and proteins in biofluids. For clinical applications, the urinary proteome appears particularly attractive due to the relative low complexity compared with the plasma proteome and the noninvasive collection of urine. In this article, we review the results from pilot studies into urinary proteomics of coronary artery disease and discuss the potential of urinary proteomics in the context of pathogenesis of CVD.lld:pubmed
pubmed-article:21523916pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21523916pubmed:languageenglld:pubmed
pubmed-article:21523916pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21523916pubmed:citationSubsetIMlld:pubmed
pubmed-article:21523916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21523916pubmed:statusMEDLINElld:pubmed
pubmed-article:21523916pubmed:monthJunlld:pubmed
pubmed-article:21523916pubmed:issn1862-8354lld:pubmed
pubmed-article:21523916pubmed:authorpubmed-author:DellesChristi...lld:pubmed
pubmed-article:21523916pubmed:authorpubmed-author:DominiczakAnn...lld:pubmed
pubmed-article:21523916pubmed:authorpubmed-author:DiezJavierJlld:pubmed
pubmed-article:21523916pubmed:copyrightInfoCopyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.lld:pubmed
pubmed-article:21523916pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21523916pubmed:volume5lld:pubmed
pubmed-article:21523916pubmed:ownerNLMlld:pubmed
pubmed-article:21523916pubmed:authorsCompleteYlld:pubmed
pubmed-article:21523916pubmed:pagination222-32lld:pubmed
pubmed-article:21523916pubmed:meshHeadingpubmed-meshheading:21523916...lld:pubmed
pubmed-article:21523916pubmed:meshHeadingpubmed-meshheading:21523916...lld:pubmed
pubmed-article:21523916pubmed:meshHeadingpubmed-meshheading:21523916...lld:pubmed
pubmed-article:21523916pubmed:meshHeadingpubmed-meshheading:21523916...lld:pubmed
pubmed-article:21523916pubmed:meshHeadingpubmed-meshheading:21523916...lld:pubmed
pubmed-article:21523916pubmed:meshHeadingpubmed-meshheading:21523916...lld:pubmed
pubmed-article:21523916pubmed:meshHeadingpubmed-meshheading:21523916...lld:pubmed
pubmed-article:21523916pubmed:meshHeadingpubmed-meshheading:21523916...lld:pubmed
pubmed-article:21523916pubmed:year2011lld:pubmed
pubmed-article:21523916pubmed:articleTitleUrinary proteomics in cardiovascular disease: Achievements, limits and hopes.lld:pubmed
pubmed-article:21523916pubmed:affiliationInstitute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. christian.delles@glasgow.ac.uklld:pubmed
pubmed-article:21523916pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21523916pubmed:publicationTypeReviewlld:pubmed
pubmed-article:21523916pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed